Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)

Historic Preferred Stock Liabilities for GeneDx Holdings (WGS) over the last 2 years, with Q2 2021 value amounting to $334.4 million.

  • GeneDx Holdings' Preferred Stock Liabilities changed N/A to $334.4 million in Q2 2021 from the same period last year, while for Jun 2021 it was $334.4 million, marking a year-over-year change of. This contributed to the annual value of $334.4 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that GeneDx Holdings reported Preferred Stock Liabilities of $334.4 million as of Q2 2021.
  • GeneDx Holdings' Preferred Stock Liabilities' 5-year high stood at $334.4 million during Q4 2020, with a 5-year trough of $334.4 million in Q4 2020.